Delivery Order SPE2DB20D3103-SPE2DB23FN7G1
Award Date 6/15/23
Potential Completion Date 6/16/23
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $11,000.22 and a completion date of July 8, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of Feraheme (ferumoxytol) 510 mg/17 ml vials to the U.S. government. The contract, valued at $7,212.20, was awarded on July 29, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of August 1, 2022. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $16,135.83, is for the delivery of Feraheme 510 mg/17 ml vials to support military treatment programs and facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential ceiling value of up to $999,999,999 through December 2025. The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,833.38, is for the delivery of Feraheme 510 mg/17 ml vial medical products. It is a firm fixed-price delivery order contract with a period of performance through March 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,292.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Feraheme, a 510 mg/17 ml vial used for medical treatments. The contract is a firm-fixed-price delivery order with a performance period extending through May 2, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Feraheme 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $54,916.16 and a performance period extending to July 7, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Feraheme (ferumoxytol) 510 mg/17 mL vials. The $14,668.64 firm fixed-price contract has a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these injectable iron replacement therapy products to support military healthcare providers and programs. This contract is a task order under a larger DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,382.64 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract has a completion date of November 21, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- On January 30, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $24,877.65 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price, non-competitive delivery order is scheduled for completion by February 2, 2026, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Feraheme 510 mg/17 ml vials, with a ceiling value of $4,478.39. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...